ArticleACG case reports journal2026

Dual Targeted Therapy With Risankizumab and Upadacitinib in Refractory Ulcerative Colitis.

Padmavathi Srivoleti et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.